![Enrique Poradosu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Enrique Poradosu
Founder at
NUVECTIS PHARMA, INC.
Net worth: 39 M $ as of 30/07/2026
Profile
Enrique Poradosu is the founder of Nuvectis Pharma, Inc., founded in 2020, and holds the title of Executive VP, Chief Scientific & Business Officer.
Former jobs include Vice President-Business & Scientific Strategy at Keryx Biopharmaceuticals, Inc. from 2003 to 2016, and Senior VP-Business & Scientific Strategy at Stemline Therapeutics, Inc. from 2016 to 2020.
Education includes undergraduate and doctorate degrees from The Hebrew University of Jerusalem.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 12/04/2026 | 1,806,319 ( 5.73% ) | 39 M $ | 30/07/2026 |
Enrique Poradosu active positions
| Companies | Position | Start |
|---|---|---|
| NUVECTIS PHARMA, INC. | Founder | 26/07/2020 |
Former positions of Enrique Poradosu
| Companies | Position | End |
|---|---|---|
| STEMLINE THERAPEUTICS, INC. | Corporate Officer/Principal | 30/11/2020 |
| KERYX BIOPHARMACEUTICALS | Chief Tech/Sci/R&D Officer | 31/12/2015 |
Training of Enrique Poradosu
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
51
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Stemline Therapeutics, Inc.
 Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvectis Pharma, Inc.
 Nuvectis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer | Health Technology |
- Stock Market
- Insiders
- Enrique Poradosu
